Over 10,000 patients, caregivers, healthcare professionals, policy makers and the general public from 136 countries have signed the world’s only Global Atrial Fibrillation Patient Charter calling for government action to help prevent millions of people from dying or becoming disabled by a stroke caused by Atrial Fibrillation (AF). To learn more, see: Global Support Increases …
Read More
StopAfib interviews Dr. James Reiffel Find a transcript and more on Dr. Reiffel at: www.stopafib.org In this video interview at Heart Rhythm 2012, Dr. James Reiffel updates us on new directions in drug treatments for atrial fibrillation. He talks about the combination of ranolazine (Ranexa) and dronedarone (Multaq), both used …
Read More
At Heart Rhythm 2012, Dr. James Reiffel gave us an update on new medications for treating atrial fibrillation, including the combination of low doses of ranolazine (Ranexa) and dronedarone (Multaq). He also talked about rate control vs. rhythm control for afib, and how the decision can vary by age and level of symptoms. Watch the …
Read More